Back to Search
ANTHONY D'AMICO, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1689794083IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
11595(MT)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations.
PMID 19395186·Int J Radiat Oncol Biol Phys·2010
4-observational
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.
PMID 19540066·Int J Radiat Oncol Biol Phys·2010
4-observational
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer.
PMID 19589569·Urology·2010
8-other
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR.
PMID 19603064·Eur J Hum Genet·2010
8-other
Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy.
PMID 19309692·Hum Mutat·2009
8-other
Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
PMID 19506151·J Clin Oncol·2009
4-observational
Probiotic use and clindamycin-induced hypercholesterolemia.
PMID 19450164·J Altern Complement Med·2009
5-case
Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.
PMID 19597029·J Clin Oncol·2009
8-other
Differential cannabinoid receptor expression during reactive gliosis: a possible implication for a nonpsychotropic neuroprotection.
PMID 19347234·ScientificWorldJournal·2009
6-review
Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
PMID 19233568·Int J Radiat Oncol Biol Phys·2009
4-observational
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
PMID 19299310·Neurology·2009
4-observational
Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era.
PMID 19286330·Int J Radiat Oncol Biol Phys·2009
8-other
Mathematical rigor is necessary, but for men with prostate cancer, clinical relevance is the priority.
PMID 19237624·J Clin Oncol·2009
8-other
Chemical sensitivity of self-assembled porphyrin nano-aggregates.
PMID 19417346·Nanotechnology·2009
8-other
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations.
PMID 19252935·Neurogenetics·2009
8-other
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
PMID 19395184·Int J Radiat Oncol Biol Phys·2009
4-observational
Reliability of the North Star Ambulatory Assessment in a multicentric setting.
PMID 19553120·Neuromuscul Disord·2009
3-trial
Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
PMID 19152438·Cancer·2009
8-other
Mitochondrial encephalomyopathies and related syndromes: brief review.
PMID 19334348·Endocr Dev·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3205 S RUSSELL ST
MISSOULA, MT 59801 - Phone
- (406) 721-4906
Quick Facts
- NPI
- 1689794083
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile